Psilocine derivatives are used as serotonin-generating psychological relaxants and medications for the treatment of central nervous system (CNS) disorders.

VN10059450BActive Publication Date: 2026-07-15MINDSET PHARMA INC

View PDF 0 Cites 0 Cited by

Patent Information

Application Number: VN1202205595
Authority / Receiving Office: VN · VN
Patent Type: Patents
Current Assignee / Owner
Filing Date: 2021-02-04
Publication Date: 2026-07-15
Estimated Expiration: 2041-02-04

Application Information

Patent Timeline

04 Feb 2021

Application

VN1202205595

15 Jul 2026

Publication

VN10059450B

Inventors: Abdelmalik SLASSI; Joseph ARAUJO

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Abstract

The invention relates to psilocin derivatives of formula (I), and pharmaceutical preparations containing them. These derivatives are capable of being used in the activation of serotonin receptors in cells, as well as in the treatment of diseases, disorders or pathological conditions by activating serotonin receptors in cells.

Need to check novelty before this filing date? Find Prior Art